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Key points:  
(1) There is a strong relationship between sleep disturbance and depression 
(2) Longitudinal studies suggest that insomnia or poor sleep may precede depression 
(3) Objective (EEG) studies demonstrate a specific profile of sleep disturbance in 
depression, particularly in respect of a dominance of REM sleep 







This paper focuses on several aspects of the relationship between sleep and depression, with particular attention to 
objective factors and subjective perceptions. It does not address the effect that antidepressants have on sleep, nor does it 
explore the wider implications of the types and course of depression, age, or other psychiatric conditions. ‘Normal 
sleep’ is explored, examining typical sleep architecture in individuals without sleep disorders, psychiatric conditions or 
physical illness. Sleep disorders are reviewed and examined to present the nature of the disturbance and the role that 
they may play in depression, with particular attention paid to insomnia. Studies have identified a sub-group of insomnia 
patients (highly distressed poor sleepers), who appear to be less satisfied with their sleep quality than ‘low distressed 
poor sleepers’, even though they did not differ on sleep timing perceptions. Recent work has shown that depressed 
individuals to be less satisfied with sleep quality than healthy controls, even though they did not differ on sleep timing 
perceptions. The evidence presented here supports the view that subjective sleep perceptions play an important role in 
depression. Poor subjective perceptions of sleep in depression may be associated with faulty cognitions. This has been 
found extensively in insomnia, but is under-researched in depression.  
 
Normal sleep 
The average adult human spends between 6½ and 8 hours sleeping, usually at a regular time each 
night [1]. It is argued that circadian rhythms regulate sleep over an approximate 25-hour daily 
schedule [2], managed by the individual, using cues from the environment, such as clocks and 
sunlight/darkness, to maintain a 24-hour cycle [3].  
 
Sleep electroencephalography (EEG) has shown that sleep progresses through a series of stages that 
represent the depth of sleep [4]. Traditionally, these stages are defined by guidelines that are 
universally accepted [5], although not entirely without critics [6]. Stage 1 is a light sleep represented 
on sleep EEG by mixed frequency, low amplitude waves is similar to alert wakefulness [7], but is 
easily distinguished from it [8]. Stage 1 sleep accounts for about 2-5% of the overall sleep episode 
in healthy young adults. Stage 2 is characterised by sleep spindles (rapid bursts of high amplitude 
activity) and K-complexes (bi-phasic waves of sharply contrasting high and low amplitude). This 
stage represents about 55% of the sleep episode [8]. Stage 3 is represented by slower sleep waves of 
higher amplitude, and lower frequency. In Stage 4, the deepest sleep, the delta activity of low 
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frequency, high-amplitude, waves become more pronounced [7]. Stages 3 and 4 represent slow-
wave sleep (SWS) and occupy about 13-25% of the overall sleep episode [8].  
 
Across the night, sleep is normally divided into 4 to 6 cyclic progressions. In normal young adults 
SWS predominates the first third of the sleep episode. After the first cycle, Stage 1 sleep becomes 
punctuated by periods of intense brain activity, known as rapid-eye-movement (REM) sleep [9], so 
called because of the appearance of frequent and intense bursts of eye movement, but with an 
almost total lack of muscle tone elsewhere in the body. REM sleep is commonly associated with 
dreaming. Sleep stages 1-4, are regarded as non-REM (NREM) sleep. After the initial progression 
to deeper SWS sleep the progression between sleep stages is erratic, although cycling between 
NREM/REM stages is more predictable, typically following a 90-120 minute cycle [8]. 
 
The first REM period in normal sleep occurs between 60 and 110 minutes after sleep initiation [3], 
and REM sleep periods generally get progressively longer and denser, as the night progresses (a few 
minutes in the initial REM stages to 30 minutes or more in the final stages). Figures 1 and 2 
demonstrate sleep, produced by sleep EEG; Figure 1 represents a healthy individual, Figure 2 shows 
sleep for a depressed individual.  
 
FIGURES 1 & 2 
 
The debate over the individual functions of REM versus NREM remains largely unresolved. 
Hartmann [4] argued that there are distinct types of sleep, represented by the sleep stages, which 
provide separate functions for the sleeper. It has been proposed that SWS provides physical 
restoration, and is fairly constant between sleepers [4]. Factors such as daytime exercise can lead to 
variations in SWS, with increased activity resulting in more SWS in the subsequent sleep episode 
[4]. On the other hand, lighter sleep, and particularly REM sleep appears to fluctuate more 
according to the sleeper’s psychological needs [10].  
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It has also been shown that human growth hormone (GH) is secreted during SWS; several studies 
have confirmed the positive relationship between SWS and GH [11]. GH depletion may be 
associated with poor quality of life. One recent study showed that 9 patients with deficient GH 
presented less SWS, less overall sleep, greater sleep fragmentation and poorer quality of sleep than 
9 healthy controls [12].  Poorer sleep quality may be associated with subsequent quality of life.  
 
REM sleep is commonly associated with dreaming. Dreams can often reflect current thinking styles 
and mood. Consequently, most dreaming is pleasurable [13]. As will be seen later, depressed 
individuals have been found to spend more time in REM sleep than healthy controls. Given the 
earlier discussions, a predominance of REM sleep at the expense of SWS, may be associated with 
less physical restoration, less GH release, more sleep fragmentation and poorer quality of life. 
Depression is associated with generally negative cognitions [14], so it could be expected that 
depression is also associated with negative dreams. However, this may help with the self-regulation 
of mood. One study [15] demonstrated that 39 of 61 participants presented symptoms of depression, 
using the Beck Depression Inventory (BDI; [16]). Of these, more than three-quarters reported 
negative dreams. They were more likely to be remitted at follow-up than those who did not report 
negative dreams. This may represent a within-sleep mood regulation, particularly earlier in the 
condition. Later sleep negativity may be associated with poorer cognition. On the other hand, the 
continuation of negative thoughts in sleep, as well as daytime cognition, may serve to exacerbate 
the condition. Furthermore, most antidepressants suppress REM sleep and reduce dreaming and yet 
are associated with an improvement in mood; this is more likely to support the latter argument 
rather than the former.   
 
Nevertheless, trying to precisely define a specific role for either REM sleep or NREM sleep may be 
fruitless, given the complexity and interactive nature of sleep stages and architecture [17]. Part of the 
problem may be the way in which sleep is measured and scored. The gold standard for ‘scoring’ 
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sleep was defined in 1968 by Rechtschaffen and Kales [5]. Since then, much has been learned about 
sleep that suggests this reference system may need to be updated to reflect current knowledge and 
research. Several researchers have suggested revision; a recent review summarises the points and 
draws upon clinical and research experience [6].  
 
Himanen and Hasan [6] argue that the Rechtschaffen and Kales system is sufficient for most normal 
sleepers, but is unable to address those with more complex and disturbed sleep. A single channel of 
EEG, supported by electrooculography (EOG) to detect eye movement and electromyography 
(EMG) to measure muscle activity, detects electrical activity and movement from a very limited 
source across the scalp; it is possible that several areas need to be examined, particularly in 
disturbed sleep. Normal sleep is associated with fewer sleep-stage changes; current EEG scoring 
techniques fail to account for the rapid and frequent changes observed in disturbed sleep. The 
complexity of sleep, particularly for those with disturbed sleep, presents conflicts when making 
decisions on scoring ambiguous sleep stages. There may be features of more than one sleep stage in 
any one epoch; currently the most predominant stage is selected. However, it is possible that there 
should be several sub-stages within each stage, or more stages to reflect current knowledge of sleep 
complexity [6].  
 
Dyssomnias 
The dyssomnias refer to disruptions to the timing, quality and amount of sleep, and are dominated 
by research focusing on insomnia. The association between insomnia (and to a lesser extent 




Narcolepsy is a neurological disorder, in which the patient may present excessive daytime 
sleepiness (EDS), frequent daytime naps or lapses into sleep, hypnagogic hallucinations, cataplexy, 
and sleep paralysis [18]. EDS is a primary diagnostic criterion for narcolepsy. It can present as 
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subjective feelings of sleepiness, or as sudden irresistible sleep attacks [19]. Although sleep attacks 
can be frequent, nocturnal sleep is still disturbed, and patients’ total 24-hour sleep is rarely longer 
than normal. Hypnagogic hallucinations refer to often frightening images that occur at sleep onset. 
They are usually visual, but can be auditory. Frequently these hallucinations relate to perceptions of 
intruders, or people (or animals) standing over the patient (or being under the bed) [20]. The 
perception of these experiences appears so real that the patient often needs reassurance from their 
bed partner [19]. Some perceptions can be so intense that the patient is considered psychotic.  
 
Cataplexy is represented by sudden collapsing, in association with intense emotion (usually 
laughter, but occasionally anger) with total loss of muscle tone. Frequently, the knees give way 
leading to collapse but, whilst abrupt, the patient usually has sufficient time to find support to avoid 
injury; consciousness is preserved [19]. Sleep paralysis is often experienced just before or 
immediately after sleep. The individual is unable to move, but remains awake and conscious; this 
can be very frightening.   Patients cannot open their eyes but yet feel awake. This state is often 
associated with hypnagogic hallucinations (or hypnopompic hallucinations if waking), which make 
the experience more frightening [19]. Narcoleptic patients often experience disturbed and 
fragmented nocturnal sleep, albeit with short sleep onset. Nocturnal disturbances can also be 
associated with periodic limb movement disorders (such as restless legs), sleep apnea, REM sleep 
behaviour disorders and sleep talking, all of which add to the unpleasant nature of this experience 
[19].  
 
Several studies suggest that there is an association between narcolepsy and depression. In one study 
examining 305 members of the UK Narcolepsy Patient Association [21], subjects demonstrated 
significantly poorer quality of life perceptions, as measured by the short-form 36 scale (SF-36 [22]), 
compared to normative data. In contrast, when 45 narcoleptic patients were compared to 50 
controls, the lifetime frequency of depression did not differ [23].  
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By definition, narcolepsy is associated with sleep-onset REM (SOREM) and increased REM 
density; shortened REM latency and greater REM density are also common with depression [24].   
The narcoleptic symptoms of EDS may also explain the association with depression, as can frequent 
nocturnal disturbance. Cataplexy in narcolepsy is often treated successfully with antidepressants 
associated with REM sleep suppression. This action appears to improve mood and reduce 
cataplexy, sleep paralysis and hypnagogic hallucinations. The most common treatment is the 
tricyclic antidepressant clomipramine, which has also been found to alleviate EDS, although some 
selective serotonin reuptake inhibitors (SSRIs), such as fluvoxamine and paroxetine, have also 
shown positive results [19] and psychostimulants such as modafinil can be used [25].  
 
Sleep apnea 
Obstructive sleep apnea (OSA) patients experience repetitive cessations of breathing during sleep, 
similar to choking, which cause brief arousals followed by ‘snoring’ that marks the return to normal 
breathing [1]. Whilst primarily a physical condition, OSA can be associated with personality 
changes, depression and anxiety, as well as poor daytime function [26]. Several studies have sought 
to examine the association between OSA and depression. In one study [27], 2271 patients with 
suspected OSA, were examined for psychiatric symptoms. Females showed significantly higher 
levels of depression in severe OSA than in milder cases, although males showed no such 
relationship. Another study [28], demonstrated that OSA patients (n=60) showed poorer SF-36 
scores than controls (n=34), and poorer perceptions on the Epworth Sleepiness Scale (ESS; [29]) and 
the Zung Self-rated Depression Scale (SDS; [30]). In a recent epidemiological study [31], patients 
with breathing-related sleep disorders, including OSA, had higher rates of major depressive 
disorder, and vice versa, even after controlling for obesity and hypertension.  
 
A number of correlation studies have examined the extent of the relationship between OSA and 
depression. For example, in a study of 49 OSA patients [32], 32% demonstrated high depression 
scores on the Minnesota Multiphasic Personality Inventory (MMPI; [33])  compared to 49 healthy 
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controls. On the other hand, some studies have failed to find an association between OSA and 
depression. One study [34] examined 95 elderly subjects at baseline, of whom 42 were available at 
five-year follow-up; 10 of these had presented mild OSA at baseline and 32 had no symptoms. 
Depressive symptoms did not differ between these groups. The problem here is that OSA was only 
measured at baseline, telling us nothing about follow-up profiles. Even so, the severity of OSA at 
baseline was mild, perhaps explaining the low level of association with depression.  
 
It is possible that the association between OSA and depression has been overstated. One review [26], 
examined 16 studies that explored the relationship. The authors categorised those studies which 
highlighted a strong relationship (9), those which that suggest that depression is secondary to OSA, 
or at least resolved by treating the OSA (5), and 2 studies which claimed no association at all. Those 
studies which propose that the relationship between OSA and depression is secondary also claim 
that the association is no more prevalent than in any other chronic illness [35]. In one study, 
although OSA was associated with depression, that relationship disappeared when controlling for 
age, body mass and hypertension [36].  
 
Those who claim that there is no relationship at all (e.g. Lee, 1990 [37]) argue that depression in 
OSA is overstated because the primary condition is ‘psychologised’ by using scales such as MMPI 
and BDI, which use vegetative symptoms in the depression cluster, thus giving a false positive. The 
authors prefer to use ‘clinical experience’ to observe for signs of mental disorder. However, this is 
only replicable if observations are made through standardised interviews and quantifiable scales 
[26].  
 
A partial explanation for the association between OSA and depression can be found in sleep 
architecture. OSA is associated with frequent arousals from sleep, which have an impact on EDS 
[38]. This is probably a key factor in associated depression [39]. OSA also presents significant 
increases in Stage 1 sleep, usually at the expense of REM sleep and SWS. In some cases SWS is 
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completely abolished; the patient will not be aware of this, but may feel like they are not refreshed 
upon waking. This may also explain some of the association with depression. However, the 
reduction in REM sleep would not explain such an association [40]; depression is often related to 
increased REM sleep, especially shorter REM latency [41]. On the other hand, it has been shown 
that OSA patients with depression present greater REM sleep percentage than OSA patients without 
depression [42]. This perhaps highlights the interaction of OSA and depression and indicates that 
sleep EEG produces confounding results in each condition [38].  
 
Treatment studies also provide some insight into the relationship between OSA and depression. The 
standard treatment for OSA is a mechanical device called ‘continuous positive airway pressure’ 
(CPAP). Several studies have shown that the use of CPAP reduces depressive symptoms, in 
addition to successfully treating the OSA [43], although not all studies agree [44]. A possible 
explanation for conflicting results is that CPAP treatment involves patients wearing an intrusive 
device over the nose (and sometimes mouth). This may affect compliance, especially in depressed 
populations [45]. Another problem is that there is no direct correlation between OSA severity and 
mood improvement after CPAP, but depression severity does affect response to CPAP [46].  
 
A final point relates to the direction of relationship between OSA and depression. It seems logical 
that OSA is more likely to cause depression, rather than vice versa. However, treatments for 
depression and related insomnia may have an impact on OSA. Some depressed patients require 
additional medication as an adjunct to their antidepressant to treat insomnia. Hypnotic medications 
may adversely affect the dilator muscles responsible for OSA and make the situation worse [47].  
 
Restless Legs Syndrome and Periodic Limb Movement Disorder 
Restless legs syndrome (RLS) is the subjective feeling of unpleasant physical sensations in the legs, 
often accompanied by observable ‘periodic limb movements’, or ‘leg jerks’. RLS tends to occur 
near bedtime, often associated with early or middle insomnia and can result in EDS [48]. RLS can 
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present from childhood to old age, but is more common with increasing age [49], and in women [50]. 
The diagnostic criteria for RLS require all of the following to be met: an urge to move the legs, 
usually accompanied by uncomfortable or unpleasant sensations in the legs; those feelings and 
urges begin or worsen during periods of rest or inactivity (such as lying or sitting); those feelings 
and urges are relieved, at least partially, by moving the legs, but only for as long as that activity 
continues; those feelings and urges are worse in the evening or night than during the day [51]. RLS 
is often reported in obstructive sleep apnea, narcolepsy, and REM sleep behaviour disorder [52]. 
RLS can also be associated with depression.  In one study [53], RLS patients (n=103) demonstrated 
significantly poorer Hamilton Rating Scale for Depression (HAMD [54]) scores than controls. In 
another study [55], 369 participants were assessed for RLS. Overall prevalence was 9.8% and was 
significantly more common in women (13.9%) than men (6.1%); participants with RLS presented a 
significantly greater incidence of depression than those without RLS.  
 
More recently, Winkelmann et al. examined the risk factors for depression in RLS [56]. Healthy 
controls (n=4181) were drawn from an earlier community survey. RLS patients reported 
significantly higher 12-month rates of depression than controls (Odds Ratio (OR) = 2.6) and were 
significantly more likely to present with comorbid depression (OR 2.1). RLS patients were 
significantly more likely to attribute their depression as being the result of RLS (OR 24.9). 
However, significant associations were also found with several anxiety symptoms. RLS can be a 
side effect of antidepressant treatment, e.g. with mianserin [57] or mirtazapine [58].  
 
Circadian rhythm sleep disorders (CRSD) 
CRSD represent a group of sleep disorders that share a common profile: a misalignment between 
the patient’s sleep patterns and those considered to the societal norm [59]. Typically, sleep occurs at 
the wrong time of day, or is out of phase with normal, and includes sleep disorders such as jet lag, 
shift work, and sleep phase syndromes, each of which are explored separately below. However, 
each of them shares features that might explain any possible association with depression. CRSD not 
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only present changes in timing, which may be associated with EDS, but also with other circadian 
rhythm-related factors, such as melatonin release and body temperature [60]. Melatonin may be of 
particular relevance, as it is also implicated in depression; several studies have shown reduced 
melatonin levels in depression [61]. Melatonin depletion is observed in CRSD [62]. Melatonin is 
easily administered, and has been shown to successfully treat shift work [63] and delayed sleep 
phase syndrome [64].  
 
Time Zone Change (Jet Lag) Syndrome 
Jet lag is a phenomenon associated with travel across time zones, which may be associated with 
fatigue, poor concentration, irritability and depression. The effect appears to be most pronounced on 
trips over several zones involving forward shifts in time. In one study [65], sleep was disrupted, and 
depression ratings were poorer, in male volunteers whose flight involved a 7-hour forward time 
shift, but not in one involving a 7-hour backward time shift. Further analyses suggested that the 
forward-time-shift flights were associated with increased REM production [66]. The authors suggest 
that daylight may be implicated in changes to the melatonin rhythm, although melatonin treatment 
for jet lag is less well supported than other CRSD [60].  
 
Shift work sleep disorder 
Individuals who are subject to regular shift work appear to be more prone to significant problems 
relating to physical and mental health, including depression. In one study [67], nearly 82% of 
Japanese shift workers (n=174) presented insomnia, autonomic dysfunction and other physical 
complaints, while 18.4% were diagnosed with depression. A community study involving 2570 
participants included 360 working rotating shifts, 174 on night shifts, with the remainder on normal 
day shifts [68]. Those working abnormal shifts, who presented EDS or insomnia, also presented 
significantly more depression, absenteeism and sleep-related accidents.  
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Sleep Phase Syndromes 
Advanced sleep phase syndrome (ASPS) is typical in older people, and is represented by earlier 
retirement to bed and early morning awakening. Delayed sleep phase syndrome (DSPS), often seen 
in younger people, involves later sleep onset times (often beyond normal social hours) and late 
morning waking [69]. ASPS has been associated with depression [70], but DSPS receives most 
attention in the literature. In one study [71], three-quarters of sleep-disorder patients (n=33), with a 
mean bedtime of 04:00 am and a mean wake time of 10:38 am, had a current, or historical, 
diagnosis of depression; for one-half of these the depression was resistant to treatment.  
.  
Parasomnias 
Parasomnias are represented by undesirable physical and behavioural abnormalities during sleep 
that are frequently disturbing (and occasionally hazardous) to the sleeper or their bed partner. 
Typically these involve unusual arousals, movements or perceptions.  
 
Nightmares, night terrors and sleepwalking 
Nightmares occur during REM sleep; the sleeper usually recalls the dream, often waking soon after 
as a result [1]. Night terrors and sleepwalking tend to occur during non-REM sleep, with the sleeper 
usually having no recall of the event. Night terrors are an abrupt arousal from sleep, often 
accompanied by panic and screaming [72]. Sleepwalking is relatively mild, compared to the often 
dramatic characteristics of sleep terrors. Sleepwalkers appear to be oblivious to the surrounding 
environment, presenting a blank expression, and clumsy purposeless activity [1].  
 
Studies that address the relationship between these conditions and depression are scarce. One study 
of more than 5000 French participants [73], found that 18.3% of those with insomnia (n=1049) 
reported nightmares. These were significantly associated with multiple awakenings, increased sleep 
latency, poor memory and greater anxiety during the proceeding day. Nightmares were also 
significantly associated with depression in women, but not men. However, it has been suggested 
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that it is the distress associated with those reports of nightmares that are related to depression, rather 
than the nightmare itself [74]. In a large British sample (n=4972) [72], 30.4% of those reporting night 
terrors, and 14.6% of those reporting sleepwalking, were significantly more likely to have diagnosis 
of major depression than controls (5.7%). 
 
REM Sleep Behaviour Disorder 
Normally, dreaming is devoid of physical activity because of reduced (almost paralysed) muscle 
tone during REM sleep. REM Sleep Behaviour Disorder is a rare condition, whereby the dreamer 
‘acts out’ the dream, sometimes violently [75]. There is some evidence suggesting an association 
with depression [76]. In the Ohayon study [72], violent behaviour in sleep was reported in 2.1% of 
participants. This group reported more night terrors, daytime sleepiness, and hypnagogic 
hallucinations (often visions of being attacked), than those not reporting the behaviour. They were 
also more likely to have reported symptoms of depression and anxiety in the prior year.  
 
Because so little research has been conducted specifically examining the association between REM 
sleep behaviour disorder and depression, and never in controlled conditions, this should be viewed 
with caution. This is true of any sleep disorder, but particularly parasomnias, which have been less 
rigorously examined than narcolepsy, OSA and RLS. A recent study sought to rectify the paucity of 
research in some sleep disorders and their association with depression [77]. They recruited 917 
patients from a Dutch sleep disorders clinic (aged 18-84 years). The authors examined the 
prevalence of associated depression with the primary sleep disorder using the BDI; a score of 10 or 
more indicates the possible presence of depression. At least some presence of depression was found 
in OSA (41%), insomnia (43%), narcolepsy (37%), RLS (53%), DSPS (41%), ASPS (83%), and 
parasomnias (29%). However the detection of depression, using the BDI, was based on subjective 
feelings, rather than clinical syndromes; the sample sizes in some disorders (e.g. ASPS n=5) was 
low; and the findings probably have little reliability in clinical settings. There is still a need for 
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larger, more controlled studies to fully understand the relationship between sleep disorders and 
depression.  
 
Insomnia and hypersomnia 
Insomnia is the most common of the dyssomnias and is diagnosed when the patient reports at least 2 
weeks of problems initiating or maintaining sleep, or with early morning awakening, nearly 
everyday [1]. DSM-IV specifies that these symptoms prevail for a month or more, and are 
associated with significant distress and impairment in normal functioning [78]. Hypersomnia is 
marked by excessive sleep [79], defined as sleeping too much nearly every day for two weeks.  
 
The relationship between sleep disturbance, particularly insomnia, and depression has received 
much attention, and is divided between those studies that focus on subjective assessment of sleep, 
and those that examine objective measurement. In one review [80], it was noted that one-third of 
patients with chronic sleep problems present mood disorders and that most patients with mood 
disorders experience insomnia and, less often hypersomnia. The relationship between sleep and 
psychiatric conditions is illustrated in an earlier meta-analysis [81]. They studied data from 177 
research investigations, involving over 7000 patients and controls. Poor sleep was implicated in 
most psychiatric disorders, but only affective disorders showed a significant difference to controls 
on all variables. Sleep EEG analyses showed that depressed patients demonstrated shorter total 
sleep time, longer sleep latency, less slow-wave sleep, shorter REM latency, and greater REM 
density, compared to controls. No other psychiatric disorder demonstrated the same contrast to 
controls.  
 
Disturbed sleep may be a symptom of depression, or it may be a prodrome. The causal direction of 
insomnia and depression is not clear, but longitudinal studies have helped to provide some 
indication. In one seminal study [82], nearly 8000 US patients were examined at baseline and 
followed-up one year later. At baseline, the prevalence of insomnia and hypersomnia was 10.2% 
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and 3.2% respectively.  Furthermore, 40% of those with insomnia and 46.5% with hypersomnia had 
a comorbid psychiatric disorder (16.4% had no sleep complaint). Follow-up measures indicated that 
the risk of developing new cases of depression was nearly 40 times greater when insomnia was 
present at both interviews, compared to an absence of insomnia. The risk of developing new cases 
of depression was less than two times greater for those whose insomnia was resolved, compared to 
those who did not have insomnia at baseline either. These findings underlie the risk for depression 
associated with persistent insomnia.  
 
In another study [79], conducted over 3.5 years, 1007 patients were examined. At baseline 31.1% of 
participants with insomnia, 25.3% with hypersomnia, and 54.3% with the combined condition also 
reported symptoms of major depression. When a revised ‘diagnosis’ of depression (excluding sleep 
disturbance as a criterion) was used the association of depression was reduced, but remained 
significant (22%; 18%; 37%). The relative risk of developing a ‘first’ diagnosis of depression by the 
3.5 year follow-up period was found to be 15.9% of participants who had presented a history of 
insomnia at baseline, compared to 4.6% of participants without that history.  Adjusted figures 
demonstrated that patients with history of insomnia at baseline were four times more likely to 
develop new depression, and almost three times more likely to do so with a history of hypersomnia.  
 
In a more specific longitudinal study [83], more than 1000 US medical school graduates were 
examined while students, and then followed up since leaving (up to 45 yrs). One-tenth of former 
students developed depression. The relative rate of depression was more than twice as great for 
those who had reported insomnia at medical school, and 1.8 times greater for those reporting sleep 
difficulty (compared to those who did not).  This shows the risk that insomnia presents for 
depression can persist over time.  
 
The relationship between insomnia and depression also appears to depend on the severity of the 
sleep complaint. In a study of more than 2500 German patients in primary care [84], assessed at 
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baseline, 4 months and 2 years, the presence of depression at follow-up was much stronger if 
patients presented severe insomnia at baseline. This was also confirmed in a US study involving 
1814 primary care patients over 2 years [85]. At baseline, 16% of patients presented severe 
insomnia, and 34% mild. At follow-up, 59% of those with mild insomnia, and 83% of those with 
severe insomnia, still had sleep problems. Odds ratio risk factors associated with depression were 
2.6 for those with mild insomnia, and 8.2 with severe insomnia, compared to rates of depression 
with those not presenting insomnia at all.  
 
Using data from the HAM-D and BDI for 14 subjects remitted from depression [86], it was found 
that recurrence was associated with increased levels of sleep disturbance prior to that recurrence. 
Chi-square analyses showed that a significantly greater proportion of recurrent subjects complained 
of insomnia symptoms than those who were still in remission (85.7% vs. 28.7%; p<.05). The same 
authors demonstrated subjective sleep complaints and EEG sleep abnormalities are associated with 
risk of the onset of ‘first ever’ depression, and to recurrence of depression [87].  
 
Objective factors 
The most common form of objective sleep measuring technique is the sleep EEG. This involves 
placing small electrodes on the scalp of the participant. From these, the EEG recording device 
detects minuscule traces of electricity between pairs of these electrodes. Sleep EEG differs from 
traditional EEG, in that it uses fewer electrodes; the purpose of sleep EEG is to detect amplitude 
and waveform of electrical signals across sleep stages, and to measure eye-movement and muscle 
activity to illustrate REM sleep.  
 
An obstacle to using traditional EEG, particularly in research, is the cost of equipment, the need for 
specialist training in application of electrodes and ‘reading’ EEG output, the time need to attach 
electrodes for each night of recording, and the inconvenience to participants. Also, most EEG 
recordings are conducted in the laboratory, thus losing ecological validity. Even with portable EEG 
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devices, the participant needs to visit the laboratory daily to have the electrodes refitted. The 
journey home from the laboratory can cause some embarrassment whilst wearing the electrodes. 
Consequently, some researchers prefer to use other methods.  
 
Wrist actigraphy involves strapping a small, watch-sized, device to the non-dominant wrist [88]. It is 
easier to fit, can be worn for several days at a time, and is considered to be more acceptable to the 
wearer [89]. It is also cheaper (typically one device costs £250) and downloads data to software 
programmes without the need for much expertise. The actigraph detects motor activity (body 
movement) and the researcher is able to accurately establish whether the subject is asleep or awake 
[89]. Actigraphy has been shown to have a high correlation with traditional EEG, particularly in 
respect of ‘total sleep’ [89]. However, wrist actigraphy cannot be used for sleep staging [88], nor can 
it recognise the appearance of REM sleep.  
 
The Nightcap [90;91], involves two crucial sensors: one that is applied to the eyelid using adhesive 
tape to detect rapid-eye-movements, and a mercury switch to monitor body movement. The sensors 
are attached to a headband or cap, which is easily fitted by the participant. The Nightcap is 
relatively inexpensive, is easy to fit and can be worn in the patient’s home and has shown good 
correlation with subjective sleep reports [91] and objective EEG recordings [90]. The Nightcap has 
been found to reliably detect sleep states (in normal populations) and has an 87% accuracy rate 
compared to sleep EEG [92], 93% concordance for NREM states and 80% for REM states [91], and 
has been found to reliably distinguish between good and poor sleepers [92]. However, the Nightcap 
cannot detect sleep stages, nor can it measure the depth of sleep and density of REM counts.  
 
EEG variables 
EEG studies consistently report their findings using a standardised set of sleep variables and 
associated abbreviations. Those abbreviations help reduce the length and complexity of reported 
data; a list of variables and abbreviations is displayed in Table 1. Typical sleep EEG hypnograms 
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for a healthy individual and a depressed patient are presented in Figures 1 and 2 respectively. The 
depressed patient presents more trouble initiating sleep, attempting sleep on several occasions and 
waking again, before finally progressing to maintained sleep; sleep initiation is much quicker for 
the healthy individual. The depressed patient shows the first appearance of REM sleep much earlier 
than the healthy individual (as shown by the shaded boxes), and wakes more frequently 
(demonstrated by the spindle peaks in the lower display). The healthy individual spent more time in 
the deeper stages of sleep (stages 3 & 4) than the depressed patient and shows fewer and less 




Several EEG studies report the extent of sleep disruption in depression. In one study [93], depressed 
patients (n=56) demonstrated reduced TST, greater SL, more REM sleep, less SWS, less SE, more 
WASO, and shorter REML sleep than controls (n=41), and more WMINS, shorter REML, and 
greater REMD compared to primary insomnia patients (n=18). In addition to those findings, a 
review [41] confirmed that depressed patients spent longer time in REM during the first REM 
period, compared to non-depressed controls. In the Benca review [81], depressed patients 
consistently demonstrated shorter TST, longer SL, less SWS, shorter REML and greater REMD 
than controls. Whilst several sleep abnormalities also appeared in other psychiatric disorders only 
depressed subjects presented all of them in such magnitude. In particular, the degree of REM sleep 
variation appears to be the factor most associated with depression.  
 
While insomnia and depression are frequently associated, the profile of sleep disturbance is quite 
different between them. One study [94], found that sleep onset times did not differ between those 
rated with primary insomnia (n=21) and major depression (n=21), or healthy controls (n=21). 
However, the control group presented significantly fewer problems maintaining sleep than 
experimental groups, in respect of TST, SE and WMINS; the depressed group slept more 
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productively than the insomnia group. Both experimental groups exceeded healthy volunteers in 
respect of WASO, but the depressed group spent significantly more time in Stage 1 sleep and REM 
sleep than the insomnia group, who spent significantly longer in SWS than the depressed group. 
Whereas the healthy volunteers, and to lesser extent the insomnia group, showed increases in SWS 
activity in the first NREM-REM period, the depressed group demonstrated no change.  
 
 
Studies also suggest that the abnormal sleep architecture observed in depression persists beyond the 
index episode [95]. Thirteen depressed patients were examined while depressed and when remitted 
for 6 months. There was no significant difference between when the patient was depressed to when 
remitted in respect of REMD, REML, TST, or the amount of time spent in REM sleep. Eleven of 
depressed patients showed reduced REML whilst ill; 8 of these were still reduced at remission.  
 
REM latency 
There is consistent and conclusive evidence that shortened REM latency is a key indicator for the 
vulnerability for depression. Kupfer [96] confirmed that shortened REML is a strong predictor of 
depression, present in almost all primary depressed patients, but absent in those with secondary 
conditions. One way of examining the potential for REML as a predictor for depression is to 
explore its presence in (non-depressed) first-degree relatives of depressed patients. Studies suggest 
that sleep may have a genetic component [97]. There is also evidence that suggests that psychiatric 
conditions, including depression, may be genetically transmitted [98]. Therefore, it seems reasonable 
to expect that the risk factor for depression posed by sleep abnormalities is also genetic.  
 
REM sleep and family concordance in depression has been examined extensively by Donna Giles 
and her colleagues. In one study [99], the relative risk of depression in relatives with reduced REML 
was almost three times greater than for relatives without shortened REML. In a later study [100], 
first-degree relatives of depressed probands, with reduced REML, were shown to present similar 
polysomnography in other sleep parameters as those seen in the depressed group, even though none 
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of the relatives were depressed at assessment. Reduced REML also appears to be stable regardless 
of whether depression is new or recurrent [101]. In a more recent study [102], it was demonstrated that 
REML predicted lifetime history of depression. This risk was almost twice as high in relatives of 
depressed probands, where the relatives had reduced REML, compared to relatives with normal 
REML. This suggests that reduced REML is associated with a risk for depression beyond the 
normal family risk, and that sleep abnormalities may precede depression and be a risk factor for it. 
 
Subjective factors 
While objective measures of sleep disturbance clearly have their place in addressing the nature of 
the relationship with depression, there is a need to address the key role that subjective factors play; 
this is an area that has been under researched previously. The perception of sleep is a very personal 
one; each individual can place a different emphasis on the importance of sleep. Insomnia in 
particular is regarded as a subjective complaint, confirmed by the clinician’s observation. The 
extent that insomnia can precede depression indicates the importance of subjective perceptions of 
sleep. Furthermore, depression has a large subjective element, especially in respect of cognitive 
aspects, such as guilt, self-esteem, pessimism, memory, concentration, motivation, and mood.  
 
Methods of measurement  
Sleep perceptions are usually collated from diaries, which can be compared to self-reported quality 
of life questionnaires or to clinician-rated scales that diagnose the nature and severity of psychiatric 
conditions. These can be very useful in obtaining important information about how an individual 
assesses the length and quality of their sleep.  
 
The Pittsburgh Sleep Quality Index (PSQI; [103]) is a self-rated questionnaire of sleep quality and 
disturbance that is completed over one month. It comprises seven components (subjective sleep 
quality, sleep latency, total sleep time, habitual sleep efficiency, sleep disturbance, use of sleep 
medications, and daytime dysfunction), which lead to one global score. A study of 168 subjects 
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indicated that PSQI was able to significantly distinguish good and poor sleepers, with a sensitivity 
of 89.6% and specificity of 86.5% [103].  
 
The Leeds Sleep Evaluation Questionnaire (LSEQ; [104]) uses 10 self-rated questions relating to 
sleep and early morning behaviour, which produce four sleep factors: ease of getting to sleep 
(GTS), quality of sleep (QOS), awakening from sleep (AFS), and behaviour following wakefulness 
(BFW). The questionnaire has been used widely in psychopharmacological studies to examine 
subjective sleep reports as the results of drug-taking behaviour [105]. It has been shown to have good 
internal consistency across each of the four factors (GTS, α=.83; QOS, r=.72; AFS, r=.77; BFW, 
α=.91) [106]. The LSEQ has been shown to reliably measure the effects of antidepressants on sleep 
[107].  
 
The Pittsburgh Sleep Diary (PghSD; [108]) includes two diaries. The bedtime diary requires 
participants to record events from the preceding day, including meals, caffeine, alcohol, and 
tobacco consumption, medication taken, levels of exercise and the number of naps taken. The wake 
time diary, completed the next morning, asks participants about various aspects of the previous 
night’s sleep, including time to bed and length of sleep initiation, and the number and length of 
nocturnal awakenings. The diary also requires the subject to rate various aspects of their sleep 
satisfaction. In a cohort of 234 participants, subjective sleep ratings correlated well with objective 
(actigraphy) measures, and the diary was sensitive to distinguish between poor and good sleepers 
[108]. Insomnia patients were found to report significantly more, and longer, nocturnal awakenings 
and reported poorer perceptions of sleep-quality, mood on awakening and alertness on awakening 
than controls.  
 
Accuracy of subjective sleep reporting 
A potential criticism of subjective sleep perceptions focuses on how accurate these perceptions are, 
compared to objective measures (such as sleep EEG). Most of the published work here focuses on 
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insomnia, and some on healthy populations; few studies have explored this in depression. In a study 
of 173 patients presenting with insomnia [109], it was shown that insomniacs generally tend to 
underestimate TST. Differences in between subjective reports of sleep and objective measures have 
also been found in patients with sleep apnea [110]. All the patients with suspected sleep apnea 
(n=84) were shown to overestimate SL and underestimate TST, but the differences were greater for 
those diagnosed with sleep apnea. In a study of eight healthy participants, measured over eight 
nights, subjective ratings appeared to correlate to sleep efficiency, but not to stages, suggesting 
inaccuracy in respect of depth of sleep, but not to quantity [111].  
 
In depression, one study suggested that there was good correlation on all measures except the 
number of wakings after sleep onset (WASO), between depressed outpatients (n=52) and healthy 
controls (n=49) [112]. However, there was a poorer correlation for perceptions of sleep quality, depth 
of sleep and feelings of being ‘rested’ on waking, in the depressed group. Another study suggested 
that all participants were inaccurate, but depressed patients (n=30) were more inaccurate than 
controls (n=10) [113]. The authors illustrated that objectively measured slow wave sleep in 
depressed patients was synonymous with subjective estimates of TST, while the density of REM 
sleep was related to perceptions of WASO. The extent of accuracy may be related to illness 
severity. One study of 23 depressed patients sought to examine this [114], and found that the extent 
of inaccurate subjective sleep reporting increased with the severity of depression. However, the 
extent of any difference in the accuracy of sleep reporting may prove less important than the way in 
which depressed patients react differently to perceived changes in sleep timing.  
 
Sleep satisfaction  
Perhaps one of the key aspects in subjective sleep reporting in depression is the extent that patients 
present negative perceptions. This might reflect the pervasive nature of cognitions in depression 
[14]. Negative cognition in the sleep perceptions of insomniacs has been widely research, but 
depression gets very little attention in this respect. Argyropoulos et al. [115] conclude that sleep 
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disturbance in depression has a strong (negative) cognitive element that may explain the inaccuracy 
of subjective sleep reporting in depression. Lee et al. [116] found that depressed patients in remission 
reported improvements in subjective sleep quality, even though EEG recordings of sleep did not 
show improvements.  
 
However, cognitive models of sleep tend to focus on insomnia [117]. Cognitive disturbance, such as 
worry and fear of insufficient sleep has been implicated in maintaining insomnia [118]. In particular, 
pre-sleep cognitive activity has been associated with negative thoughts and worry, especially about 
getting to sleep [119]. A study of 30 insomnia patients [118] showed significantly higher Beck 
Anxiety Inventory (BAI; [120]) scores than 30 healthy controls, but did not differ on BDI scores; 
perhaps studies are needed to explore these cognitions in the sleep of depressed individuals.  
 
Furthermore, not only do insomniacs tend to worry about getting to sleep, they also worry about the 
consequences of not getting enough sleep, ‘catastrophising’ the impact on daytime function, work 
performance, social relationships and self-esteem [121]. This serves to exacerbate the sleep problem.  
Given the emphasis on cognitive models for insomnia, it is not surprising that cognitive behaviour 
therapy (CBT) has been identified as a potential treatment [122]. Should negative cognition also be 
shown to maintain negative subjective sleep in depression then CBT may be useful in treating those 
thoughts. One possible indication to the presence of faulty cognition in depression focuses on 
another theory for the function of REM sleep. Johnson argues that the suppression of noradrenergic 
activity in REM sleep may be associated with reduced rationality and logical sequencing (often a 
feature of dreams), and with perpetuating emotion [123]. For the depressed individual that may be 
represented by increased negative emotion. Since many antidepressants suppress REM sleep, this 
may partly explain the lifting of mood and the improvement in subjective sleep perception observed 
by Lee [116].   
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Fichten and colleagues [124;125] described a sub-group of insomnia patients who demonstrated ‘sleep 
distress’. Highly distressed poor sleepers demonstrated more reports of difficulty with daytime 
function, tension and depression than those low distressed poor sleepers, even though those groups 
did not differ in respect of perceived sleep timing. From this, it could follow that ‘poor sleepers’, 
who report least satisfaction with their sleep, may be at greater risk for future depression than those 
who are less distressed by sleep perceptions.  
 
More recently, subjective sleep satisfaction has been extended to depressed populations. In one 
study [126], 20 depressed patients were compared to 20 healthy controls. The depressed group 
reported significantly poorer perceptions of sleep quality, perceptions of ‘sufficient sleep’, and 
perceptions of feeling ‘rested upon waking’, even though perceptions of sleep timing were similar 
between the groups. Clearly the depressed group were demonstrating poorer sleep satisfaction than 
controls. A similar finding was found in a second cohort of 18 depressed patients and 18 healthy 
controls [127]. On this occasion a group of 10 first-degree relatives of each group were recruited. In 
addition to the sleep distress factor, there was a non-significant trend for the relatives of the 
depressed group to report sleep in similar way to their depressed relatives; no such correlation was 
seen between the healthy controls and their relatives.  
 
In a sample of 26 participants, recruited from a depression self-help group [128], perceptions of sleep 
timing were not related to perceptions of sleep satisfaction or mood/quality of life perceptions. 
However, perceptions of sleep satisfaction were related to mood/quality of life perceptions. 
Furthermore, perceptions of current depression were related to sleep satisfaction; history of 
insomnia was not. Sleep timing perceptions could not be explained by any factor, nor did they 
predict other variables, whereas variance in sleep satisfaction was explained by subjective 
depression. Participants with current subjective depression showed greater changes to sleep 





The relationship between disturbed sleep and depression has been widely researched. While 
everyone probably experiences some kind of sleep disturbance during their lifetime, this is 
generally brief and rarely interferes significantly with daily living. However, for some sleep 
disturbance is chronic.  Sometimes that disturbance is perceived, with no apparent objectively 
measured difference in the timing of their sleep patterns to those not reporting sleep problems. 
Nevertheless, their distress poses a significant enough problem that might contribute to depression.  
 
Other, more observable, sleep disturbances are also associated with depression. Studies have 
suggested associations between depression and narcolepsy [21]; obstructive sleep apnea [27;28;31;32] 
and Restless Legs Syndrome [53;55;56], but not all research agrees [23;34;36;37]. The propensity to sleep 
depends on environmental cues to maintain a fully functional 24-hour circadian cycle [2]. It would 
seem logical that any disruption to these cues may lead to problematic sleep, possibly affect mood 
in the process. Time zone changes, shift work and sleep phase abnormalities have all been 
associated with depression [65;67;68;70;71]. Parasomnias have been linked less with depression, and 
any association may be the result of distress with the individuals’ reports of frequent nightmares or 
other violent disruptions from sleep (such as night terrors or sleepwalking) [72;74;76].  
 
Most studies support a significant relationship between insomnia and depression [80]. The key 
studies in this respect have focused on longitudinal analyses, each showing that a baseline diagnosis 
or history of insomnia presents a significantly greater risk of depression at follow-up than when 
there is no such diagnosis [79;82;83]. The severity and chronicity of insomnia also appears to be 
positively correlated with depression severity [84;85].  
 
Objectively measured observations of sleep confirm the extent and nature of disruption to sleep 
architecture in depression [81]. Depressed individuals consistently demonstrate less total sleep time, 
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greater problems initiating sleep, more trouble maintaining sleep and poorer sleep efficiency than 
healthy controls [93]. REM sleep variables are also significantly altered in depression; patients 
frequently show shorter REM sleep latency, more frequent and more intense REM production, and 
less deeper, slow-wave, sleep than healthy individuals [41]. While these profiles are seen 
individually in other forms of mental disorder, none other shows the same extent and intensity of 
REM sleep disruption, especially in the first NREM-REM period [81]. Although insomnia and 
depression are frequently associated, studies have shown sleep disruption in depression to be 
different to those seen in insomnia. Depressed individuals particularly differ to insomniacs in 
respect of REM latency and density [93]. REM latency may represent a significant marker for the 
risk of depression [102].  
 
Subjective factors are also important. Sleep EEG may demonstrate what is happening to the 
structure of sleep, but the individual’s perception of sleep sufficiency and quality might illustrate 
how people react to even small changes in sleep patterns. Whether those subjective assessments of 
sleep are accurate when compared to objectively measured techniques may not be as crucial as 
some researchers argue. Indeed, subjective sleep satisfaction has been shown to be an important 
factor in insomnia [124;125] and depression [126-128], and may represent a cognitive bias towards 
negativity in the poor sleeper [115;117-119;121;123;129]. However, this research tends to focus more on 
insomnia patients; more work is needed to explore cognitive biases towards sleep in depression.  
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Table 1: Sleep Variable Abbreviations  
 
Sleep Variable Abbreviation Refers to 
Total Sleep Time TST Total time spent asleep during the measured episode  
Time in bed TIB Time spent in bed, whether asleep or not 
Sleep Latency SL Length of time taken to initiate sleep 
Sleep Efficiency SE Proportion of time spent asleep during the episode (TST ÷ TIB) 
Wakings After Sleep Onset WASO Number of times awake during the sleep episode, once sleep initiated 
Waking Minutes WMINS The length of those awakenings  
Rapid eye movement (sleep)  REM Light, almost wake-like, sleep typified by rapid eye movements but 
associated with a lack of movement elsewhere 
Non-REM sleep NREM Any sleep not involving REM 
Slow Wave Sleep SWS Periods of deeper NREM sleep 
REM Sleep Latency REML Length of time from sleep onset to first appearance of REM 









Figure 2: Sleep EEG representing a depressed patient (from [130]) 
 
 
 
